Acute myocardial infarction in a patient with essential thrombocythemia: Successful treatment with percutaneous transluminal coronary recanalization

Circulation Journal

Volumn 69, Issue 8, 2005, Pages 1000-1002

  Mizuta, Einosuke ^a   Takeda, Shin Ichi ^b   Sasaki, Norihito ^b   Miake, Junichiro ^a   Hamada, Toshiriro ^b   Shimoyama, Masaki ^b   Tajima, Fumihito ^b   Igawa, Osamu ^b   Shigemasa, Chiaki ^b   Hisatome, Ichiro ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

Author keywords

Acute myocardial infarction; Essential thrombocythemia; Percutaneous transluminal coronary recanalization

Indexed keywords

ACETYLSALICYLIC ACID; CREATINE KINASE; HEPARIN; HYDROXYUREA; TICLOPIDINE; UROKINASE; WARFARIN;

ACUTE HEART INFARCTION; ADULT; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; CASE REPORT; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; DISEASE COURSE; ECCHYMOMA; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REPERFUSION; HEART VENTRICLE WALL MOTION; HEART VENTRICULOGRAPHY; HEMATOMA; HOSPITAL ADMISSION; HUMAN; RECANALIZATION; SURGICAL TECHNIQUE; THROMBOGENESIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; THROMBUS; TRANSLUMINAL CORONARY RECANALIZATION;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FEMALE; HUMANS; MYOCARDIAL INFARCTION; PLASMINOGEN ACTIVATORS; THROMBOCYTHEMIA, HEMORRHAGIC; URINARY PLASMINOGEN ACTIVATOR;

EID: 23744468233     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.69.1000     Document Type: Article

References (16)

1. Epstein E, Goedel A. Hamorrhagische Thrombozytamie bei vaskularer Schrumpfmils. Virchows Arch Pathol Anat 1934; 292: 233-248.
2. Gunz FW. A critical review. Blood 1960; 15: 706-723.
3. Silverstein MN. Primary or hemorrhagic thrombocythemia. Arch Intern Med 1968; 122: 18-22.
4. Bellucci S, Janvier M, Tobelem G. Essential Thrombocythemia: Clinical evolutionary and biological data. Cancer 1986; 58: 2440-2447.
5. Preston FE. Essential thrombocythemia. Lancet 1982; 1: 1021.
6. Lofvenberg E, Nordenson I, Wahlin A. Cytogenetic abnormalities and leukemic transformation in hydroxyurea-treated patients with Philadelphia chromosome negative chronic myeloproliferative disease. Cancer Genet Cytogenet 1990; 49: 57-67.
7. Rossi C, Randi ML, Zervinati P, Rinaldi V, Girolami A. Acute coronary disease in essential thrombocythemia and polycythemia vera. J Intern Med 1998; 244: 49-53.
8. van Genderen PJJ, Michiels JJ. Primary thrombocythemia: Diagnosis, clinical manifestations and management. Ann Hematol 1993; 67: 57-62.
9. Cortelazzo S, Finazzi G, Ruggeri M, Vestri O, Galli M, Rodeghiero F, et al. Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis. N Engl J Med 1995; 332: 1132-1136.
10. Nagata Y, Usuda K, Uchiyama A, Uchikoshi M, Sekiguchi Y, Kato H, et al. Characteristics of the pathological images of coronary artery thrombi according to the infarct-related coronary artery in acute myocardial infarction. Circ J 2004; 68: 308-314.
11. Goto S. Understanding the mechanism and prevention of arterial occlusive thrombus formation by anti-platelet agents. Curr Med Chem Cardiovasc Hematol Agents 2004; 2: 149-156.
12. Dardik R, Ruggeri ZM, Savion N, Gitel S, Martinowitz U, Chu V, et al. Platelet aggregation on extracellular matrix: Effect of a recombinant GPIb-binding fragment of von Willebrand factor. Thromb Haemost 1993; 70: 522-526.
13. Kumagai K, Fukuchi M, Ohta J, Baba S, Oda K, Akimoto H, et al. Expression of the von Willebrand factor in atrial endocardium is increased in atrial fibrillation depending on the extent of structural remodeling. Circ J 2004; 68: 321-327.
14. Marchese P, Murata M, Mazzucato M, Pradella P, De Marco L, Ware J, et al. Identification of three tyrosine residues of glycoprotein Ib alpha with distinct roles in von Willebrand factor and alphathrombin binding. J Biol Chem 1995; 270: 9571-9578.
15. Murata M, Matsubara Y, Kawano K, Zama T, Aoki N, Yoshino H, et al. Coronary artery disease and polymorphisms in a receptor mediating shear stress-dependent platelet activation. Circulation 1997; 96: 3281-3286.
16. Fuster V, Badimon L, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992; 326: 242- 250, 310-318.